Juan J. Lozano
Barcelona, CT 08036, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 166 publications
Correction: Pérez et al. Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines 2025, 13, 740.
Journal: Biomedicines
Published: July 03, 2026
Corrigendum to "Maladaptive emergency granulopoiesis predicts poor outcomes in patients hospitalized with decompensated cirrhosis" [J Hepatol (2026) 749-765].
Journal: Journal of hepatology
Published: April 23, 2026
Equilibrative nucleoside transporter 1 deficiency protects against diet-induced MASLD and is stage-associated in human liver disease.
Journal: Metabolism: clinical and experimental
Published: January 21, 2026
Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 17, 2025
Validation of the CLIF-SIG score in patients with HBV-related acutely decompensated cirrhosis.
Journal: Gut
Published: May 06, 2025
Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinoma.
Journal: Nature communications
Published: May 04, 2025
GDF15 is associated with hepatocellular senescence and correlates with mortality in patients with alcohol-associated hepatitis.
Journal: JHEP reports : innovation in hepatology
Published: January 24, 2025
miR-27b-3p modulates liver sinusoidal endothelium dedifferentiation in chronic liver disease.
Journal: Hepatology communications
Published: October 24, 2024
Characterization of the Regulatory Landscape in Crohn's Disease Reveals microRNA-Associated Alterations that Shape Anti-TNF Response.
Journal: Inflammatory bowel diseases
Published: October 15, 2024
Last Updated: 09/26/2026